Daniela Latorre
@LatorreDanielaa
Group Leader at @SanRaffaeleMI/ CDA & ERC Awardee/ Human immunology - neurological disorders - T cells. Ex Group leader at @ETH_DBIOL. Trained in @sallustolab.
🔬 Delighted to share our lab's debut paper in @Nature. We unveil the first proof of autoreactive CD4+and CD8+ #Tcells infiltrating and targeting peripheral nerves in #Guillain-Barré Syndrome patients, reshaping our understanding of #GBS #autoimmunity. 👉 nature.com/articles/s4158…
Groundbreaking discovery!
Exciting discovery: CSF flow isn't confined to the brain and spinal cord—it also extends to peripheral nerves! @ScienceMagazine science.org/doi/10.1126/sc… Groundbreaking research from @UFHealth @UF #neurotwitter #neuroscience #AcademicChatter
Passionate about #immunology? Join my lab to study #autoreactive #Tcells in #neurological disorders. 🔬Lab Manager 🔬Lab Technician 🔬Postdocs @SanRaffaeleMI @MyUniSR @y_efis @SiicaI @syis_ecr linkedin.com/posts/daniela-…
APERTE LE CANDIDATURE PER IL CAREER DEVELOPMENT AWARD 2025 🧬👩🔬🧑🔬⚗️ 📅Scadenza il 15 luglio 2025 PER CANDIDARSI 👇👇👇 armeniseharvard.org/apply-2/career… #grant #armeniseharvard #Science #Italy
Are you an immunologist interested in spatially-resolved single cell technologies and generative modeling but dont know where to start? Check out our @EurJImmunol review with Avital, Hosna, Robert Zeiser, @IdoAmitLab, @YosefLab & @WertheimerT onlinelibrary.wiley.com/doi/10.1002/ej…
Proud to be part of this #global initiative to raise #awareness about the Global Threats to #AcademicResearch and the urgent need for collective action. This is the joint effort of 16 #youngscientists from 11 countries 🌍✨, who first connected at the #WLA in Shanghai in 2023.
What’s preventing scientists from making breakthroughs that could save and improve your life? Check out our latest publication sciencedirect.com/science/articl… @The_InnovationJ @CellPressNews @GaelleOP @chemFunMan @JosieNeuro @gfico @Dr_Ponkratov_LR @LatorreDanielaa @micromotility
Exciting times ahead! @ERC_Research @ArmeniseHarvard #ERCCoG @MyUniSR @SanRaffaeleMI 🔗 Found out more here: lnkd.in/dqyBbYQh lnkd.in/diW-s_iH Stay tuned—opportunities to join our team are coming soon!
The @ERC_Research Consolidator Grants for 2024 have been assigned. In the Life Sciences field, 4 projects have been funded in Italy, 3 of which were awarded to San Raffaele. Congratulations to our researchers! 🎉
🎓 Join us at INEM! Two postdoc positions in the "Immunity in Health & Disease" lab @FillatreauSimon: 1⃣ T cell therapy for Type 1 Diabetes (@ARTiDeTregT1D) 👉 institut-necker-enfants-malades.fr/index.php/offr… 2⃣ Microglia biology in neuroinflammatory disease 👉 institut-necker-enfants-malades.fr/index.php/offr… Spread the word! 🌟
I will still be here for a while, but start following me on the other side 👉🔬@lablatorre.bsky.social #bsky
Interested in pursuing a PhD thesis in our group in Demark? Interested in droplets, immune cells and cellular functions? Then definitely apply! phd.health.au.dk/application/op…
Great talks by @JagodicLab @LatorreDanielaa and Marina Boziki on hot topics in basic and clinical neuroimmunology #ECTRIMS2024. Great partnership between @ISNI_neuro and @ECTRIMS. @FabienneBrilot #WeAreNeuroimmunology
Excited to give a talk on Immunological similarities and differences between #Guillain-Barré Syndrome and #MS at #ECTRIMS24 in beautiful Copenhagen. @ISNI_neuro @ECTRIMS

Check it out our latest review in @EurJImmunol on Guillain–Barré syndrome #GBS, exploring recent advances in its #immunopathology and novel clinical implications, building on our recent discovery of #Tcell immunity involvement. doi.org/10.1002/eji.20…
If you are convinced that microbes are causal of infectious diseases, please take a breath, and consider the alternative possibility that infection with a trigger microbe reveals a preexisting cause of disease in the host: annualreviews.org/content/journa…
Glad to serve as a guest Editor together with @ramibechara for the special Issue @EurJImmunol on Immune crosstalk in #autoimmunity. Now open for submission.
📢Special Issue: Crosstalk between Hematopoietic and Non-hematopoietic Cells in Autoimmunity is open for submissions bit.ly/3yHv69B. Guest editors: @LatorreDanielaa and @ramibechara. Meet @ramibechara at #EULAR2024. @EFIS_Immunology @y_efis @RomagnaniLab @iannaconelab
Excited to connect with #SYISnetwork and #earlycareerscientists! Quick question: What would you prefer to hear from me—deeper dives into scientific data or insights into my personal journey through science and career? Cast your vote in the poll below! @syis_ecr @y_efis
Join us for another exciting seminar! @LatorreDanielaa and Natascha Wuillemin will talk about T cell immunity and treatment of allergies! @y_efis
#Tcells rock!!! Beautiful study from @iannaconelab . Many congratulations Matteo and team!
💥 Exciting News! Our latest research is now online @NatImmunol! Discover how prior infection or vaccination provides antibody-independent protection against heterologous SARS-CoV-2 challenge! 🧵🔬 (1/10) nature.com/articles/s4159… 2/ 🛡️ Shifting paradigms, our research highlights…
🌟 Save the date! Join us for the grand finale of the yEFIS Women in Immunology 2024 campaign. 🌐 March 8th, 4pm CET: Join the Immunology webinar for groundbreaking insights and networking. Let's celebrate women in Immunology! 🎉 📌 Register here ⤵️ us06web.zoom.us/meeting/regist…
Never underestimate the power of believing in your own potential to make a meaningful difference in the world. #WomenInScience #WomenInImmunology
Dr. Daniela Latorre’s research focuses mainly on human immunology, with a primary interest on T cell immunity within the context of immune-mediated neurological diseases and microbial infections. #WomenInScience #WomenInImmunology @syis_ecr @ETH_en
Amazing environment and scientists. Highly recommended! @y_efis @syis_ecr
New Junior and/or Senior Group Leaders, Infection-Inflammation-Immunology, @InfinityTLS nature.com/naturecareers/… @Inserm @CNRS @UnivPaulSabatierToulouse
And for those still looking, remember that for there is a TCR for every antigen-MHC complex out there. Happy Valentine's.